{"a":[{"_":"Lilly, Resilience commit $750M to boost US diabetes, obesity med production","$":{"href":"/manufacturing/lilly-resilience-plot-750m-outlay-increase-production-injectables-ohio","hreflang":"en"}}]}

Summary

Eli Lilly and CDMO Resilience announced a $750 million joint investment to increase production capacity for Lilly's KwikPen injectable device used in diabetes and obesity medicines Mounjaro and Zepbound.